Literature DB >> 21532586

WWP2 is an E3 ubiquitin ligase for PTEN.

Subbareddy Maddika1, Sridhar Kavela, Neelam Rani, Vivek Reddy Palicharla, Jenny L Pokorny, Jann N Sarkaria, Junjie Chen.   

Abstract

PTEN, a lipid phosphatase, is one of the most frequently mutated tumour suppressors in human cancer. Several recent studies have highlighted the importance of ubiquitylation in regulating PTEN tumour-suppressor function, but the enzymatic machinery required for PTEN ubiquitylation is not clear. In this study, by using a tandem affinity-purification approach, we have identified WWP2 (also known as atrophin-1-interacting protein 2, AIP-2) as a PTEN-interacting protein. WWP2 is an E3 ubiquitin ligase that belongs to the NEDD4-like protein family, which is involved in regulating transcription, embryonic stem-cell fate, cellular transport and T-cell activation processes. We show that WWP2 physically interacts with PTEN and mediates its degradation through a ubiquitylation-dependent pathway. Functionally, we show that WWP2 controls cellular apoptosis and is required for tumorigenicity of cells. Collectively, our results reveal a functional E3 ubiquitin ligase for PTEN that plays a vital role in tumour-cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532586      PMCID: PMC3926303          DOI: 10.1038/ncb2240

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  40 in total

Review 1.  PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.

Authors:  Juan Paez; William R Sellers
Journal:  Cancer Treat Res       Date:  2003

2.  PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

Authors:  Muxiang Zhou; Lubing Gu; Harry W Findley; Rong Jiang; William G Woods
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

3.  Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination.

Authors:  Hui Ming Xu; Bing Liao; Qian Jun Zhang; Bei Bei Wang; Hui Li; Xiao Min Zhong; Hui Zhen Sheng; Ying Xin Zhao; Ying Ming Zhao; Ying Jin
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

4.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

5.  Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.

Authors:  B Kwabi-Addo; D Giri; K Schmidt; K Podsypanina; R Parsons; N Greenberg; M Ittmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.

Authors:  Lindsey D Mayo; Jack E Dixon; Donald L Durden; Nickolas K Tonks; David B Donner
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

7.  Functional evaluation of p53 and PTEN gene mutations in gliomas.

Authors:  H Kato; S Kato; T Kumabe; Y Sonoda; T Yoshimoto; S Kato; S Y Han; T Suzuki; H Shibata; R Kanamaru; C Ishioka
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

8.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

9.  Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel.

Authors:  Fiona J McDonald; Andrea H Western; John D McNeil; Brittany C Thomas; Diane R Olson; Peter M Snyder
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

10.  Pten dose dictates cancer progression in the prostate.

Authors:  Lloyd C Trotman; Masaru Niki; Zohar A Dotan; Jason A Koutcher; Antonio Di Cristofano; Andrew Xiao; Alan S Khoo; Pradip Roy-Burman; Norman M Greenberg; Terry Van Dyke; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  PLoS Biol       Date:  2003-10-27       Impact factor: 8.029

View more
  140 in total

Review 1.  Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.

Authors:  Benjamin D Hopkins; Ramon E Parsons
Journal:  Clin Cancer Res       Date:  2014-11-01       Impact factor: 12.531

2.  Defining the protein-protein interaction network of the human hippo pathway.

Authors:  Wenqi Wang; Xu Li; Jun Huang; Lin Feng; Keithlee G Dolinta; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

3.  Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.

Authors:  Byeong Hyeok Choi; Yan Chen; Wei Dai
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

Review 4.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

Review 5.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

6.  A Tunable Brake for HECT Ubiquitin Ligases.

Authors:  Zan Chen; Hanjie Jiang; Wei Xu; Xiaoguang Li; Daniel R Dempsey; Xiangbin Zhang; Peter Devreotes; Cynthia Wolberger; L Mario Amzel; Sandra B Gabelli; Philip A Cole
Journal:  Mol Cell       Date:  2017-05-04       Impact factor: 17.970

7.  Protein Chemical Approaches to Understanding PTEN Lipid Phosphatase Regulation.

Authors:  Daniel R Dempsey; Philip A Cole
Journal:  Methods Enzymol       Date:  2018-06-30       Impact factor: 1.600

Review 8.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

9.  Patched-1 proapoptotic activity is downregulated by modification of K1413 by the E3 ubiquitin-protein ligase Itchy homolog.

Authors:  Xiaole L Chen; Pilar Chinchilla; Joanna Fombonne; Lan Ho; Catherine Guix; James H Keen; Patrick Mehlen; Natalia A Riobo
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

10.  Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.

Authors:  Lin Yuan; Yanrong Lv; Hongchang Li; Haidong Gao; Shanshan Song; Yuan Zhang; Guichun Xing; Xiangzhen Kong; Lijing Wang; Yang Li; Tao Zhou; Daming Gao; Zhi-Xiong Xiao; Yuxin Yin; Wenyi Wei; Fuchu He; Lingqiang Zhang
Journal:  Nat Cell Biol       Date:  2015-08-17       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.